The presently disclosed inventions relate to systems and methods for processing and displaying breast tissue images, and in particular to representing high-dimensional (e.g., 3D) structures present in breast tissue image data with a high-dimensional object grid, and then reducing the high-dimensional data to a low-dimensional (e.g., 2D) format version that can be incorporated within a synthesized image to be displayed to a medical professional.
Mammography has long been used to screen for breast cancer and other abnormalities. Traditionally, mammograms have been formed on x-ray film. More recently, flat panel digital imagers have been introduced that acquire a mammogram in digital form, and thereby facilitate analysis and storage of the acquired image data, and to also provide other benefits. Further, substantial attention and technological development have been dedicated to obtaining three-dimensional images of the breast using methods such as breast tomosynthesis. In contrast to the 2D images generated by legacy mammography systems, breast tomosynthesis systems construct a 3D image volume from a series of 2D projection images, each projection image obtained at a different angular displacement of an x-ray source relative to the image detector as the x-ray source is scanned over the detector. The constructed 3D image volume is typically presented as a plurality of slices of image data, the slices being mathematically reconstructed on planes typically parallel to the imaging detector. The reconstructed tomosynthesis slices reduce or eliminate the problems caused by tissue overlap and structure noise present in single slice, two-dimensional mammography imaging, by permitting a user (e.g., a radiologist or other medical professional) to scroll through the image slices to view only the structures in that slice.
Imaging systems such as tomosynthesis systems have recently been developed for breast cancer screening and diagnosis. In particular, Hologic, Inc. (hologic.com) has developed a fused, multimode mammography/tomosynthesis system that acquires one or both types of mammogram and tomosynthesis images, either while the breast remains immobilized or in different compressions of the breast. Other companies have introduced systems that include tomosynthesis imaging; e.g., which do not include the ability to also acquire a mammogram in the same compression.
Examples of systems and methods that leverage existing medical expertise in order to facilitate, optionally, the transition to tomosynthesis technology are described in U.S. Pat. No. 7,760,924, which is hereby incorporated by reference in its entirety. In particular, U.S. Pat. No. 7,760,924 describes a method of generating a synthesized 2D image, which may optionally be displayed along with tomosynthesis projection or reconstructed images, in order to assist in screening and diagnosis.
A 2D synthesized image is designed to provide a concise representation of the 3D reconstruction slices, including any clinically important and meaningful information, such as abnormal lesions and normal breast structures, while representing in relevant part a traditional 2D image. There are many different types of lesions and breast structures, which may be defined as different types of image objects having different characteristics. For any given image object visible in the 3D volume data, it is important to maintain and enhance the image characteristics (e.g., micro-calcifications, architectural distortions, etc.) as much as possible onto the 2D synthesized image. Further, when representing multiple identified objects on the 2D synthesized image, the synthesized image may appear crowded and visually confusing. Accordingly, there exists a need for more effectively processing, synthesizing and displaying breast image data.
In one embodiment of the disclosed inventions, a method for processing breast tissue image data includes obtaining image data of a patient's breast tissue; processing the image data to generate a high-dimensional grid depicting one or more high-dimensional objects in the patient's breast tissue; determining a probability or confidence of each of the one or more high-dimensional objects depicted in the high-dimensional grid; and generating a lower-dimensional format version of the one or more high-dimensional objects for display in a synthesized image of the patient's breast tissue.
These and other aspects and embodiments of the disclosed inventions are described in more detail below, in conjunction with the accompanying figures.
The drawings illustrate the design and utility of embodiments of the disclosed inventions, in which similar elements are referred to by common reference numerals. These drawings are not necessarily drawn to scale. In order to better appreciate how the above-recited and other advantages and objects are obtained, a more particular description of the embodiments will be rendered, which are illustrated in the accompanying drawings. These drawings depict only typical embodiments of the disclosed inventions and are not therefore to be considered limiting of its scope.
All numeric values are herein assumed to be modified by the terms “about” or “approximately,” whether or not explicitly indicated, wherein the terms “about” and “approximately” generally refer to a range of numbers that one of skill in the art would consider equivalent to the recited value (i.e., having the same function or result). In some instances, the terms “about” and “approximately” may include numbers that are rounded to the nearest significant figure. The recitation of numerical ranges by endpoints includes all numbers within that range (e.g., 1 to 5 includes 1, 1.5, 2, 2.75, 3, 3.80, 4, and 5).
As used in this specification and the appended claims, the singular forms “a”, “an”, and “the” include plural referents unless the content clearly dictates otherwise. As used in this specification and the appended claims, the term “or” is generally employed in its sense including “and/or” unless the content clearly dictates otherwise. In describing the depicted embodiments of the disclosed inventions illustrated in the accompanying figures, specific terminology is employed for the sake of clarity and ease of description. However, the disclosure of this patent specification is not intended to be limited to the specific terminology so selected, and it is to be understood that each specific element includes all technical equivalents that operate in a similar manner. It is to be further understood that the various elements and/or features of different illustrative embodiments may be combined with each other and/or substituted for each other wherever possible within the scope of this disclosure and the appended claims.
Various embodiments of the disclosed inventions are described hereinafter with reference to the figures. It should be noted that the figures are not drawn to scale and that elements of similar structures or functions are represented by like reference numerals throughout the figures. It should also be noted that the figures are only intended to facilitate the description of the embodiments. They are not intended as an exhaustive description of the invention or as a limitation on the scope of the disclosed inventions, which is defined only by the appended claims and their equivalents. In addition, an illustrated embodiment of the disclosed inventions needs not have all the aspects or advantages shown. For example, an aspect or an advantage described in conjunction with a particular embodiment of the disclosed inventions is not necessarily limited to that embodiment and can be practiced in any other embodiments even if not so illustrated.
For the following defined terms and abbreviations, these definitions shall be applied throughout this patent specification and the accompanying claims, unless a different definition is given in the claims or elsewhere in this specification:
An “acquired image” refers to an image generated while visualizing a patient's tissue. Acquired images can be generated by radiation from a radiation source impacting on a radiation detector disposed on opposite sides of a patient's tissue, as in a conventional mammogram.
A “reconstructed image” refers to an image generated from data derived from a plurality of acquired images. A reconstructed image simulates an acquired image not included in the plurality of acquired images.
A “synthesized image” refers to an artificial image generated from data derived from a plurality of acquired and/or reconstructed images. A synthesized image includes elements (e.g., objects and regions) from the acquired and/or reconstructed images, but does not necessarily correspond to an image that can be acquired during visualization. Synthesized images are constructed analysis tools.
An “Mp” image is a conventional mammogram or contrast enhanced mammogram, which are two-dimensional (2D) projection images of a breast, and encompasses both a digital image as acquired by a flat panel detector or another imaging device, and the image after conventional processing to prepare it for display (e.g., to a health professional), storage (e.g., in the PACS system of a hospital), and/or other use.
A “Tp” image is an image that is similarly two-dimensional (2D), but is acquired at a respective tomosynthesis angle between the breast and the origin of the imaging x-rays (typically the focal spot of an x-ray tube), and encompasses the image as acquired, as well as the image data after being processed for display, storage, and/or other use.
A “Tr” image is a type (or subset) of a reconstructed image that is reconstructed from tomosynthesis projection images Tp, for example, in the manner described in one or more of U.S. Pat. Nos. 7,577,282, 7,606,801, 7,760,924, and 8,571,289, the disclosures of which are fully incorporated by reference herein in their entirety, wherein a Tr image represents a slice of the breast as it would appear in a projection x-ray image of that slice at any desired angle, not only at an angle used for acquiring Tp or Mp images.
An “Ms” image is a type (or subset) of a synthesized image, in particular, a synthesized 2D projection image, which simulates mammography images, such as craniocaudal (CC) or mediolateral oblique (MLO) images, and is constructed using tomosynthesis projection images Tp, tomosynthesis reconstructed images Tr, or a combination thereof. Ms images may be provided for display to a health professional or for storage in the PACS system of a hospital or another institution. Examples of methods that may be used to generate Ms images are described in the above-incorporated U.S. Pat. Nos. 7,760,924 and 8,571,289.
It should be appreciated that Tp, Tr, Ms and Mp image data encompasses information, in whatever form, that is sufficient to describe the respective image for display, further processing, or storage. The respective Mp, Ms. Tp and Tr images are typically provided in digital form prior to being displayed, with each image being defined by information that identifies the properties of each pixel in a two-dimensional array of pixels. The pixel values typically relate to respective measured, estimated, or computed responses to X-rays of corresponding volumes in the breast, i.e., voxels or columns of tissue. In a preferred embodiment, the geometry of the tomosynthesis images (Tr and Tp) and mammography images (Ms and Mp) are matched to a common coordinate system, as described in U.S. Pat. No. 7,702,142. Unless otherwise specified, such coordinate system matching is assumed to be implemented with respect to the embodiments described in the ensuing detailed description of this patent specification.
The terms “generating an image” and “transmitting an image” respectively refer to generating and transmitting information that is sufficient to describe the image for display. The generated and transmitted information is typically digital information.
In order to ensure that a synthesized 2D image displayed to an end-user (e.g., an Ms image) includes the most clinically relevant information, it is necessary to detect and identify three-dimensional (3D) objects, such as malignant breast mass, tumors, etc., within the breast tissue. In accordance with the inventions disclosed and described herein, this information may be used to create a high-dimensional grid, e.g., a 3D grid, that helps create a more accurate and enhanced rendering of the most important features in the synthesized 2D image. The high-dimensional object grid may then be used to collapse the most clinically-significant information pertaining to the identified objects to a 2D format onto one or more synthesized 2D images. Various data reduction techniques may be applied to the identified 3D objects to ensure that the most clinically-significant objects are emphasized, and less significant objects are omitted and/or de-emphasized. Additionally, or alternatively, data reduction techniques are applied to ensure that significant features of a 3D object are enhanced, while less significant features of the 3D object are de-emphasized, especially when two objects are competing for display and prominence on the one or more 2D synthesized images. Thus, as disclosed and described herein, a 3D object grid is utilized, i.e., as a component of an algorithm, for reducing high-dimensional data (e.g., 3D tomosynthesis image data) to low-dimensional data (e.g. a 2D synthesized image).
More particularly, the image generation and display system 100 includes an image acquisition system 101 that acquires tomosynthesis image data for generating Tp images of a patient's breasts, using the respective three-dimensional and/or tomosynthesis acquisition methods of any of the currently available systems. If the acquisition system is a combined tomosynthesis/mammography system, Mp images may also be generated. Some dedicated tomosynthesis systems or combined tomosynthesis/mammography systems may be adapted to accept and store legacy mammogram images, (indicated by a dashed line and legend “Mplegacy” in
The Tp images are transmitted from either the acquisition system 101, or from the storage device 102, or both, to a computer system configured as a reconstruction engine 103 that reconstructs the Tp images into reconstructed image “slices” Tr, representing breast slices of selected thickness and at selected orientations, as disclosed in the above-incorporated patents and applications.
Mode filters 107 are disposed between image acquisition and image display. The filters 107 may additionally include customized filters for each type of image (i.e., Tp, Mp, and Tr images) arranged to identify and highlight certain aspects of the respective image types. In this manner, each imaging mode can be tuned or configured in an optimal way for a specific purpose. For example, filters programmed for recognizing objects across various 2D image slices may be applied in order to detect image patterns that may belong to a particular high-dimensional object. The tuning or configuration may be automatic, based on the type of the image, or may be defined by manual input, for example through a user interface coupled to a display. In the illustrated embodiment of
The imaging and display system 100 further includes a 2D image synthesizer 104 that operates substantially in parallel with the reconstruction engine 103 for generating 2D synthesized images using a combination of one or more Tp, Mp, and/or Tr images. The 2D image synthesizer 104 consumes a set of input images (e.g., Mp, Tr and/or Tp images), determines a set of most relevant features from each of the input images, and outputs one or more synthesized 2D images. The synthesized 2D image represents a consolidated synthesized image that condenses significant portions of various slices onto one image. This provides an end-user (e.g., medical personnel, radiologist, etc.) with the most clinically-relevant image data in an efficient manner, and reduces time spent on other images that may not have significant data.
One type of relevant image data to highlight in the synthesized 2D images would be relevant objects found across one or more Mp, Tr and/or Tp images. Rather than simply assessing image patterns of interest in each of the 2D image slices, it may be helpful to determine whether any of the 2D image patterns of interest belong to a larger high-dimensional structure, and if so, to combine the identified 2D image patterns into a higher-dimensional structure. This approach has several advantages, but in particular, by identifying high-dimensional structures across various slices/depths of the breast tissue, the end-user may be better informed as to the presence of a potentially significant structure that may not be easily visible in various 2D slices of the breast.
Further, instead of identifying similar image patterns in two 2D slices (that are perhaps adjacent to each other), and determining whether or not to highlight image data from one or both of the 2D slices, identifying both image patterns as belonging to the same high-dimensional structure may allow the system to make a more accurate assessment pertaining to the nature of the structure, and consequently provide significantly more valuable information to the end-user. Also, by identifying the high-dimensional structure, the structure can be more accurately depicted on the synthesized 2D image. Yet another advantage of identifying high-dimensional structures within the various captured 2D slices of the breast tissue relates to identifying a possible size/scope of the identified higher-dimensional structure. For example, once a structure has been identified, previously unremarkable image patterns that are somewhat proximate to the high-dimensional structure may now be identified as belonging to the same structure. This may provide the end-user with an indication that the high-dimensional structure is increasing in size/scope.
To this end, the 2D image synthesizer 104 generates high-dimensional object grids 120 (e.g., 3D object grids) comprising one or more high-dimensional structures (e.g., 3D objects) present in the patient's breast tissue. Several techniques may be used to construct 3D object grids 120 that identify various objects in the breast tissue. It should be appreciated that this disclosure is not limited to 3D objects and/or structures, and may refer to even higher-dimensional structures, but for simplicity, the remaining disclosure will refer to 3D objects populated in a 3D object grid 120.
In one or more embodiments, the 3D object grid 120 is in the form of a 3D (volumetric) coordinate space representing a patient's breast mass, and identifies a location, identity, size, scope, and/or other characteristics of any objects or structures found in the breast mass. Examples of such objects or structures include calcifications, spiculated lesions, benign tumors, irregular masses, dense objects, etc.
In one or more embodiments, the end-user (e.g., a medical professional such as a radiologist) can access and interact with the 3D object grid 120. In other embodiments, the 3D object grid 120 is solely used by the system processor for constructing synthesized 2D images, and the end-user may not be aware of, or have access to, the 3D object grid 120.
In accordance with the disclosed embodiments, the 2D image synthesizer 104 also includes a data reduction module 122 configured to reduce the high-dimensional data populated in the 3D object grid 120 to a lower-dimensional format suitable for representation in a 2D synthesized image. The data reduction module 122 evaluates the various objects of the 3D object grid 120, and determines what objects (or what portions of objects) should be enhanced or emphasized in a final 2D synthesized image to be displayed to the end-user. For example, a clinically significant object and a routine background breast tissue object may have regions of overlap, in which case the data reduction module 122 is preferably configured to de-emphasize portions of the background breast tissue in order to highlight the clinically significant object. Further details on various data reduction techniques that may be employed by the data reduction module 122 are described below.
The synthesized 2D images may be viewed at a display system 105. The reconstruction engine 103 and 2D image synthesizer 104 are preferably connected to a display system 105 via a fast transmission link. The display system 105 may be part of a standard acquisition workstation (e.g., of acquisition system 101), or of a standard (multi-display) review station (not shown) that is physically remote from the acquisition system 101. In some embodiments, a display connected via a communication network may be used, for example, a display of a personal computer or of a so-called tablet, smart phone or other hand-held device. In any event, the display 105 of the system is preferably able to display respective Ms, Mp, Tr, and/or Tp images concurrently, e.g., in separate side-by-side monitors of a review workstation, although the invention may still be implemented with a single display monitor, by toggling between images.
Thus, the imaging and display system 100, which is described as for purposes of illustration and not limitation, is capable of receiving and selectively displaying tomosynthesis projection images Tp, tomosynthesis reconstruction images Tr, synthesized mammogram images Ms, and/or mammogram (including contrast mammogram) images Mp, or any one or sub combination of these image types. The system 100 employs software to convert (i.e., reconstruct) tomosynthesis images Tp into images Tr, software for synthesizing mammogram images Ms, software for decomposing 3D objects, software for creating feature maps and object maps. An object of interest or feature in a source image may be considered a ‘most relevant’ feature for inclusion in a 2D synthesized image based upon the application of the object maps along with one or more algorithms and/or heuristics, wherein the algorithms assign numerical values, weights or thresholds, to pixels or regions of the respective source images based upon identified/detected objects and features of interest within the respective region or between features. The objects and features of interest may include, for example, spiculated lesions, calcifications, and the like.
As shown in the illustrated embodiment, the tomosynthesis stack 202 comprises a plurality of images 218 taken at various depths/cross-sections of the patient's breast tissue. Some of the images 218 in the tomosynthesis stack 202 comprise 2D image patterns. Thus, the tomosynthesis stack 202 comprises a large number of input images containing various image patterns within the images of the stack.
For example, while the tomosynthesis stack 202 may comprise one hundred images 218 captured at various depths/cross sections of the patient's breast tissue, only a few of the images 218 may include any information of significance. Also, it should be noted that the tomosynthesis stack 202 contains 2D image patterns when viewed at differing z-dimension (depth) locations of the otherwise same x, y locations in the image slices 218, but it may be difficult to determine the 3D structures based only on the various individual images, each representing a finite cross-sectional image of the breast tissue. However, the tomosynthesis stack 202 may be effectively utilized to create the 3D object grid 120. In any event, for purposes of this patent specification, it is assumed that the 3D object grid 120 is constructed by any means, including but not limited to being created from the tomosynthesis stack 202.
The 3D object grid 120 may be considered a 3D volumetric coordinate space representing a patient's breast mass. Rather than depicting 2D image patterns at various image slices, the 3D object grid 120 preferably depicts any identified 3D objects in the entire mass (or portion thereof) that represents the patient's breast tissue. The 3D object grid 120 provides fuller detail regarding various objects in the breast mass as compared to the tomosynthesis stack 202. For example, the 3D object grid 120 may use simulation techniques to infer a shape of the 3D object, even though an image slice may not have necessarily been reconstructed at every cross-sectional depth covering the respective 3D object.
The 3D object grid 120 may comprise one or more objects, as shown in the illustrated embodiment. It should be appreciated that these objects may be predefined objects that the system has been trained to identify. However, even in healthy breast tissue that does not necessarily comprise any abnormal objects or structures, the target object recognition/enhancement modules may identify a breast background object. For example, all breast linear tissue and density tissue structures can be displayed as the breast background object. In other embodiments, “healthy” objects such as spherical shapes, oval shapes, etc., may simply be identified through one or more target object recognition/enhancement modules 210. These identified 3D objects may then be displayed on the 2D synthesized image 206; of course, out of all identified 2D objects, more clinically-significant objects may be prioritized and/or enhanced when displaying the respective object on the 2D synthesized image, as will be discussed in further detail below.
In one or more embodiments, the 2D synthesizer 104 utilizes both the tomosynthesis image stack 202 along with the created 3D object grid 120 in order to merge the relevant features into one or more 2D synthesized images 206. As shown in the 2D synthesized image, the 3D objects identified in the 3D object grid 120 are collapsed into a 2D format, but provide more detail when compared to individual image slices of the tomosynthesis image stack 202. Further, although several objects, as shown in the tomosynthesis image stack 202 overlap in the z direction, identifying them as separate 3D objects allows the system to depict both objects clearly and efficiently. Simply utilizing legacy image recognizing techniques on the tomosynthesis image stack 202 may or may not necessarily provide such an accurate synthesized 2D image 206. To explain, if there is overlap in the z direction of two structures, the two structures are essentially competing with each other for display on the 2D synthesized image 206. Thus, important aspects of both structures may be compromised. Or, only one of the two structures may be highlighted at all in the 2D synthesized image 206. Or, in yet another scenario, the 2D synthesized image may depict both structures as one amorphous structure such that an important structure goes entirely undetectable for the end-user.
It will be appreciated that identifying 3D objects as separate objects with predefined types in the 3D object grid 120 allows the system to depict the structures more accurately on the 2D synthesized image 206, and allows for various objects to be depicted simultaneously, even if there is an overlap of various objects in the coordinate space. Thus, utilizing the 3D object grid 120 has many advantages for producing a more accurate and visually-effective 2D synthesized image 206.
In one or more embodiments, data from the tomosynthesis stack 202 and the 3D object grid 120 are processed by one or more modules to produce the 2D synthesized image 206. More particularly, an object combination module 210 may be configured to identify the various objects of the 3D object grid 120, and determine a most optimal method to collapse all the objects on a 2D plane/format. For example, the object combination module 210 may determine x and y coordinates for the plurality of objects and determine whether there are overlaps between multiple objects to be displayed on the 2D synthesized image 206. In some embodiments, the object combination module 210 may further be configured to determine which of the identified objects should be displayed on the 2D synthesized image 206. This may be achieved through a training (or a “learning library” type) database 216 that stores an identity of various objects and associated weights of respective objects. The training database becomes more knowledgeable with the processing of each new patent breast image data, as the system derives 3D object models and (subsequently) detection mechanisms from this database, which will grow to include various samples of the same types of objects.
After the 3D objects are detected, then the next step is to utilize this same knowledge in synthesizing the 2D image. Since there may be many different types (or categories) of 3D objects, the weighting mechanism helps to combine the objects in the synthesis/data reduction process. For example, a dense spherical object may be weighed higher than a calcification (weighed 0.95 and 0.6 respectively in the illustrated embodiment), such that the dense spherical object may be enhanced to a greater degree as compared to a calcification. If the weight of an object is close to zero, the object combination module 210 may determine that the object need not be displayed at all, in some embodiments.
In one or more embodiments, an image details synthesis module 212 may be configured to determine what 3D objects or what areas within a 3D object should be emphasized in the 2D synthesized image 206. For example, if there is an overlap between two objects, the image details synthesis module 212 may emphasize portions of both objects, and de-emphasize other portions of both objects such that both objects are clearly viewable on the 2D synthesized image. By manipulating aspects of both objects, the end-user may be able to identify both objects clearly. It should be appreciated that without this manipulation, both objects may simply be overlayed on top of each other, such that one object may simply be masked out and missed by the end-user.
For example, the 3D object grid 120 may include a calcification area and a spiculated lesion that overlap in the z direction. Without any specially designed image synthesis, a collapsed 2D format of the spiculated lesion and a collapsed 2D format of the calcification would be displayed on top of each other. Assuming the spiculated mass is larger, the spiculated mass may envelop the calcification entirely such that it is not visible to the end-user. Instead, the image details synthesis module 212 may emphasize the outline of the center portion of the spiculated mass, while deemphasizing the middle portion of the spiculated mass such that the calcification area is visible. This image manipulation allows the end-user a clearer picture of significant objects on the 2D synthesized image 206.
In some embodiments, the image details synthesis module 212 may comprise several algorithms and/or heuristics that are programmed with rules to determine what parts of an object to emphasize/de-emphasize based on the object database 216. For example, each object in the database 216 may correspond to metadata that defines most prominent and least-prominent features of the respective object. This metadata may be used by the various algorithms to determine which objects and/or which parts of objects to emphasize in the 2D synthesized images 206. By way of another example, a difference in weight between two overlapping objects may be calculated in order to determine whether both objects should be displayed. If the difference in weight is smaller than a predetermined threshold value, both objects may be displayed, but the assigned weight may be used to determine which of the two objects to emphasize over the other. However, if the difference in weight is larger than the predetermined threshold value, only the object corresponding to the higher weight may be displayed at all. For example, if a dense spherical mass and calcification area are competing for display (difference of 0.35 in weight as per the illustrated embodiment) and the threshold value is set at 0.4, both objects may be displayed, but the spiculated mass (or parts of the spiculated mass) may be highlighted relative to the calcification area. However, if the spiculated mass and a benign semi-spherical mass are overlapping (difference of 0.65 in weight as per the illustrated embodiment), only the dense spherical mass may be displayed at all. Other rules may be defined to allow the system to modify the objects or portions thereof.
As noted above (and in
By contrast, referring to 2D synthesized image 308, the techniques described with respect to
In the illustrated embodiment, Tr image stack 434 comprises two Tr image slices. One Tr image slice comprises object 432, and the other Tr image slice comprises object 431. As shown in the illustrated embodiment, these objects overlap in the z direction. Thus, when collapsing the objects onto the 2D synthesized image 436, both objects 431 and 432 are represented, but are shown to overlap. Depending on weights assigned to both objects, one object may be highlighted while the other is de-emphasized. In the illustrated embodiment, both objects are represented somewhat equally, even though it is clear that they represent two separate objects. In other embodiments (not shown), if object 431 is assigned a higher weight/priority, object 431 may be emphasized in the foreground, while object 432 may be relegated to the background. Similarly, other combination techniques may be utilized to optimally represent clinically-significant information to the end-user.
For example, it may be determined that one object is much more clinically significant as compared to another. Or, it may be determined that two overlapping objects are equally significant. In this case, algorithms aiming to visually depict both objects optimally may be utilized, rather than highlighting one object over another. At step 608, based on the relative weight/priority of the objects, the 3D objects may be reduced to a 2D format to create the 2D synthesized image. This reduction process may highlight one object over another, in some embodiments. In other embodiment, the reduction process may highlight an outline of an object while de-emphasizing an interior of the object.
In yet another embodiment, the reduction process may emphasize one or more features that are deemed to be significant, while de-emphasizing less significant aspects of the same object. For example, in the case of a spiculated lesion, it may be important to display the blood supply lines emanating from the center of the spiculated mass, but the center of the spiculated mass, even if dense may be displayed with less emphasis. Any number of such enhancement techniques may be used in the data reduction process. At step 610, the synthesized 2D image is displayed to the end-user.
Having described exemplary embodiments, it should be appreciated that the examples described above and depicted in the accompanying figures are only illustrative, and that other embodiments and examples also are encompassed within the scope of the appended claims. For example, while the flow diagrams provided in the accompanying figures are illustrative of exemplary steps; the overall image merge process may be achieved in a variety of manners using other data merge methods known in the art. The system block diagrams are similarly representative only, illustrating functional delineations that are not to be viewed as limiting requirements of the disclosed inventions. It will also be apparent to those skilled in the art that various changes and modifications may be made to the depicted and/or described embodiments (e.g., the dimensions of various parts), without departing from the scope of the disclosed inventions, which is to be defined only by the following claims and their equivalents. The specification and drawings are, accordingly, to be regarded in an illustrative rather than restrictive sense.
The present application is a National Phase entry under 35 U.S.C § 371 of International Patent Application No. PCT/US2018/024912, having an international filing date of Mar. 28, 2018, which claims the benefit under 35 U.S.C. § 119 to U.S. Provisional Patent Application Ser. No. 62/479,008, filed Mar. 30, 2017, which is incorporated by reference in its entirety into the present application.
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/US2018/024912 | 3/28/2018 | WO |
Publishing Document | Publishing Date | Country | Kind |
---|---|---|---|
WO2018/183549 | 10/4/2018 | WO | A |
Number | Name | Date | Kind |
---|---|---|---|
3502878 | Stewart | Mar 1970 | A |
3863073 | Wagner | Jan 1975 | A |
3971950 | Evans et al. | Jul 1976 | A |
4160906 | Daniels | Jul 1979 | A |
4310766 | Finkenzeller et al. | Jan 1982 | A |
4496557 | Malen et al. | Jan 1985 | A |
4559641 | Caugant et al. | Dec 1985 | A |
4706269 | Reina et al. | Nov 1987 | A |
4744099 | Huettenrauch | May 1988 | A |
4773086 | Fujita | Sep 1988 | A |
4773087 | Plewes | Sep 1988 | A |
4819258 | Kleinman et al. | Apr 1989 | A |
4821727 | Levene et al. | Apr 1989 | A |
4907156 | Doi et al. | Jun 1990 | A |
4969174 | Schied | Nov 1990 | A |
4989227 | Tirelli et al. | Jan 1991 | A |
5018176 | Romeas et al. | May 1991 | A |
RE33634 | Yanaki | Jul 1991 | E |
5029193 | Saffer | Jul 1991 | A |
5051904 | Griffith | Sep 1991 | A |
5078142 | Siczek et al. | Jan 1992 | A |
5099846 | Hardy | Mar 1992 | A |
5129911 | Siczek et al. | Jul 1992 | A |
5133020 | Giger et al. | Jul 1992 | A |
5163075 | Lubinsky | Nov 1992 | A |
5164976 | Scheid et al. | Nov 1992 | A |
5199056 | Darrah | Mar 1993 | A |
5219351 | Teubner | Jun 1993 | A |
5240011 | Assa | Aug 1993 | A |
5279309 | Taylor et al. | Jan 1994 | A |
5280427 | Magnusson | Jan 1994 | A |
5289520 | Pellegrino et al. | Feb 1994 | A |
5343390 | Doi et al. | Aug 1994 | A |
5359637 | Webbe | Oct 1994 | A |
5365562 | Toker | Nov 1994 | A |
5386447 | Siczek | Jan 1995 | A |
5415169 | Siczek et al. | May 1995 | A |
5426685 | Pellegrino et al. | Jun 1995 | A |
5452367 | Bick | Sep 1995 | A |
5491627 | Zhang et al. | Feb 1996 | A |
5499097 | Ortyn et al. | Mar 1996 | A |
5506877 | Niklason et al. | Apr 1996 | A |
5526394 | Siczek | Jun 1996 | A |
5539797 | Heidsieck et al. | Jul 1996 | A |
5553111 | Moore | Sep 1996 | A |
5592562 | Rooks | Jan 1997 | A |
5594769 | Pellegrino et al. | Jan 1997 | A |
5596200 | Sharma | Jan 1997 | A |
5598454 | Franetzki | Jan 1997 | A |
5609152 | Pellegrino et al. | Mar 1997 | A |
5627869 | Andrew et al. | May 1997 | A |
5642433 | Lee et al. | Jun 1997 | A |
5642441 | Riley et al. | Jun 1997 | A |
5647025 | Frost et al. | Jul 1997 | A |
5657362 | Giger et al. | Aug 1997 | A |
5668889 | Hara | Sep 1997 | A |
5671288 | Wilhelm et al. | Sep 1997 | A |
5712890 | Spivey | Jan 1998 | A |
5719952 | Rooks | Feb 1998 | A |
5735264 | Siczek et al. | Apr 1998 | A |
5763871 | Ortyn et al. | Jun 1998 | A |
5769086 | Ritchart et al. | Jun 1998 | A |
5773832 | Sayed et al. | Jun 1998 | A |
5803912 | Siczek et al. | Sep 1998 | A |
5818898 | Tsukamoto et al. | Oct 1998 | A |
5828722 | Ploetz | Oct 1998 | A |
5835079 | Shieh | Nov 1998 | A |
5841124 | Ortyn et al. | Nov 1998 | A |
5872828 | Niklason et al. | Feb 1999 | A |
5875258 | Ortyn et al. | Feb 1999 | A |
5878104 | Ploetz | Mar 1999 | A |
5878746 | Lemelson et al. | Mar 1999 | A |
5896437 | Ploetz | Apr 1999 | A |
5941832 | Tumey | Aug 1999 | A |
5954650 | Saito | Sep 1999 | A |
5986662 | Argiro | Nov 1999 | A |
6005907 | Ploetz | Dec 1999 | A |
6022325 | Siczek et al. | Feb 2000 | A |
6067079 | Shieh | May 2000 | A |
6075879 | Roehrig et al. | Jun 2000 | A |
6091841 | Rogers | Jul 2000 | A |
6101236 | Wang et al. | Aug 2000 | A |
6102866 | Nields et al. | Aug 2000 | A |
6137527 | Abdel-Malek | Oct 2000 | A |
6141398 | He | Oct 2000 | A |
6149301 | Kautzer et al. | Nov 2000 | A |
6175117 | Komardin | Jan 2001 | B1 |
6196715 | Nambu | Mar 2001 | B1 |
6215892 | Douglass et al. | Apr 2001 | B1 |
6216540 | Nelson | Apr 2001 | B1 |
6219059 | Argiro | Apr 2001 | B1 |
6256370 | Yavus | Apr 2001 | B1 |
6233473 | Sheperd | May 2001 | B1 |
6243441 | Zur | Jun 2001 | B1 |
6245028 | Furst et al. | Jun 2001 | B1 |
6272207 | Tang | Aug 2001 | B1 |
6289235 | Webber et al. | Sep 2001 | B1 |
6292530 | Yavus | Sep 2001 | B1 |
6293282 | Lemelson | Sep 2001 | B1 |
6327336 | Gingold et al. | Dec 2001 | B1 |
6327377 | Rutenberg et al. | Dec 2001 | B1 |
6341156 | Baetz | Jan 2002 | B1 |
6375352 | Hewes | Apr 2002 | B1 |
6389104 | Bani-Hashemi et al. | May 2002 | B1 |
6411836 | Patel | Jun 2002 | B1 |
6415015 | Nicolas | Jul 2002 | B2 |
6424332 | Powell | Jul 2002 | B1 |
6442288 | Haerer | Aug 2002 | B1 |
6459925 | Nields et al. | Oct 2002 | B1 |
6463181 | Duarte | Oct 2002 | B2 |
6468226 | McIntyre, IV | Oct 2002 | B1 |
6480565 | Ning | Nov 2002 | B1 |
6501819 | Unger et al. | Dec 2002 | B2 |
6556655 | Chichereau | Apr 2003 | B1 |
6574304 | Hsieh | Jun 2003 | B1 |
6597762 | Ferrant | Jul 2003 | B1 |
6611575 | Alyassin et al. | Aug 2003 | B1 |
6620111 | Stephens et al. | Sep 2003 | B2 |
6626849 | Huitema et al. | Sep 2003 | B2 |
6633674 | Barnes | Oct 2003 | B1 |
6638235 | Miller et al. | Oct 2003 | B2 |
6647092 | Eberhard | Nov 2003 | B2 |
6650928 | Gailly | Nov 2003 | B1 |
6683934 | Zhao | Jan 2004 | B1 |
6744848 | Stanton | Jun 2004 | B2 |
6748044 | Sabol et al. | Jun 2004 | B2 |
6751285 | Eberhard | Jun 2004 | B2 |
6758824 | Miller et al. | Jul 2004 | B1 |
6813334 | Koppe | Nov 2004 | B2 |
6882700 | Wang | Apr 2005 | B2 |
6885724 | Li | Apr 2005 | B2 |
6901156 | Giger et al. | May 2005 | B2 |
6912319 | Barnes | May 2005 | B1 |
6940943 | Claus | Sep 2005 | B2 |
6978040 | Berestov | Dec 2005 | B2 |
6987331 | Koeppe | Jan 2006 | B2 |
6999554 | Mertelmeier | Feb 2006 | B2 |
7022075 | Grunwald et al. | Apr 2006 | B2 |
7025725 | Dione et al. | Apr 2006 | B2 |
7030861 | Westerman | Apr 2006 | B1 |
7110490 | Eberhard | Sep 2006 | B2 |
7110502 | Tsuji | Sep 2006 | B2 |
7117098 | Dunlay et al. | Oct 2006 | B1 |
7123684 | Jing et al. | Oct 2006 | B2 |
7127091 | OpDeBeek | Oct 2006 | B2 |
7142633 | Eberhard | Nov 2006 | B2 |
7218766 | Eberhard | May 2007 | B2 |
7245694 | Jing et al. | Jul 2007 | B2 |
7289825 | Fors et al. | Oct 2007 | B2 |
7298881 | Giger et al. | Nov 2007 | B2 |
7315607 | Ramsauer | Jan 2008 | B2 |
7319735 | Defreitas et al. | Jan 2008 | B2 |
7323692 | Rowlands | Jan 2008 | B2 |
7346381 | Okerlund et al. | Mar 2008 | B2 |
7406150 | Minyard et al. | Jul 2008 | B2 |
7430272 | Jing et al. | Sep 2008 | B2 |
7443949 | Defreitas et al. | Oct 2008 | B2 |
7466795 | Eberhard et al. | Dec 2008 | B2 |
7577282 | Gkanatsios et al. | Aug 2009 | B2 |
7606801 | Faitelson et al. | Oct 2009 | B2 |
7616801 | Gkanatsios et al. | Nov 2009 | B2 |
7630533 | Ruth et al. | Dec 2009 | B2 |
7634050 | Muller et al. | Dec 2009 | B2 |
7640051 | Krishnan | Dec 2009 | B2 |
7697660 | Ning | Apr 2010 | B2 |
7702142 | Ren et al. | Apr 2010 | B2 |
7705830 | Westerman et al. | Apr 2010 | B2 |
7760924 | Ruth et al. | Jul 2010 | B2 |
7769219 | Zahniser | Aug 2010 | B2 |
7787936 | Kressy | Aug 2010 | B2 |
7809175 | Roehrig et al. | Oct 2010 | B2 |
7828733 | Zhang et al. | Nov 2010 | B2 |
7831296 | DeFreitas et al. | Nov 2010 | B2 |
7869563 | DeFreitas | Jan 2011 | B2 |
7974924 | Holla et al. | Jul 2011 | B2 |
7991106 | Ren et al. | Aug 2011 | B2 |
8044972 | Hall et al. | Oct 2011 | B2 |
8051386 | Rosander et al. | Nov 2011 | B2 |
8126226 | Bernard et al. | Feb 2012 | B2 |
8155421 | Ren et al. | Apr 2012 | B2 |
8165365 | Bernard et al. | Apr 2012 | B2 |
8532745 | DeFreitas et al. | Sep 2013 | B2 |
8571289 | Ruth et al. | Oct 2013 | B2 |
8594274 | Hoernig et al. | Nov 2013 | B2 |
8677282 | Cragun et al. | Mar 2014 | B2 |
8712127 | Ren et al. | Apr 2014 | B2 |
8897535 | Ruth et al. | Nov 2014 | B2 |
8983156 | Periaswamy et al. | Mar 2015 | B2 |
9020579 | Smith | Apr 2015 | B2 |
9075903 | Marshall | Jul 2015 | B2 |
9084579 | Ren et al. | Jul 2015 | B2 |
9119599 | Itai | Sep 2015 | B2 |
9129362 | Jerebko | Sep 2015 | B2 |
9289183 | Karssemeijer | Mar 2016 | B2 |
9451924 | Bernard | Sep 2016 | B2 |
9456797 | Ruth et al. | Oct 2016 | B2 |
9478028 | Parthasarathy | Oct 2016 | B2 |
9589374 | Gao | Mar 2017 | B1 |
9592019 | Sugiyama | Mar 2017 | B2 |
9805507 | Chen | Oct 2017 | B2 |
9808215 | Ruth et al. | Nov 2017 | B2 |
9811758 | Ren et al. | Nov 2017 | B2 |
9901309 | DeFreitas et al. | Feb 2018 | B2 |
10008184 | Kreeger et al. | Jun 2018 | B2 |
10010302 | Ruth et al. | Jul 2018 | B2 |
10092358 | DeFreitas | Oct 2018 | B2 |
10111631 | Gkanatsios | Oct 2018 | B2 |
10242490 | Karssemeijer | Mar 2019 | B2 |
10335094 | DeFreitas | Jul 2019 | B2 |
10357211 | Smith | Jul 2019 | B2 |
10410417 | Chen et al. | Sep 2019 | B2 |
10413263 | Ruth et al. | Sep 2019 | B2 |
10444960 | Marshall | Oct 2019 | B2 |
10456213 | DeFreitas | Oct 2019 | B2 |
10573276 | Kreeger et al. | Feb 2020 | B2 |
10575807 | Gkanatsios | Mar 2020 | B2 |
10595954 | DeFreitas | Mar 2020 | B2 |
10624598 | Chen | Apr 2020 | B2 |
10977863 | Chen | Apr 2021 | B2 |
10978026 | Kreeger | Apr 2021 | B2 |
20010038681 | Stanton et al. | Nov 2001 | A1 |
20010038861 | Hsu et al. | Nov 2001 | A1 |
20020012450 | Tsuji | Jan 2002 | A1 |
20020050986 | Inoue | May 2002 | A1 |
20020075997 | Unger et al. | Jun 2002 | A1 |
20020113681 | Byram | Aug 2002 | A1 |
20020122533 | Marie et al. | Sep 2002 | A1 |
20020188466 | Barrette et al. | Dec 2002 | A1 |
20020193676 | Bodicker | Dec 2002 | A1 |
20030007598 | Wang | Jan 2003 | A1 |
20030018272 | Treado et al. | Jan 2003 | A1 |
20030026386 | Tang | Feb 2003 | A1 |
20030048260 | Matusis | Mar 2003 | A1 |
20030073895 | Nields et al. | Apr 2003 | A1 |
20030095624 | Eberhard et al. | May 2003 | A1 |
20030097055 | Yanof | May 2003 | A1 |
20030128893 | Castorina | Jul 2003 | A1 |
20030135115 | Burdette et al. | Jul 2003 | A1 |
20030169847 | Karellas | Sep 2003 | A1 |
20030194050 | Eberhard | Oct 2003 | A1 |
20030194121 | Eberhard et al. | Oct 2003 | A1 |
20030195433 | Turovskiy | Oct 2003 | A1 |
20030210254 | Doan | Nov 2003 | A1 |
20030212327 | Wang | Nov 2003 | A1 |
20030215120 | Uppaluri | Nov 2003 | A1 |
20040008809 | Webber | Jan 2004 | A1 |
20040008900 | Jabri et al. | Jan 2004 | A1 |
20040008901 | Avinash | Jan 2004 | A1 |
20040036680 | Davis | Feb 2004 | A1 |
20040047518 | Tiana | Mar 2004 | A1 |
20040052328 | Saboi | Mar 2004 | A1 |
20040064037 | Smith | Apr 2004 | A1 |
20040066884 | Claus | Apr 2004 | A1 |
20040066904 | Eberhard et al. | Apr 2004 | A1 |
20040070582 | Smith et al. | Apr 2004 | A1 |
20040077938 | Mark et al. | Apr 2004 | A1 |
20040081273 | Ning | Apr 2004 | A1 |
20040094167 | Brady | May 2004 | A1 |
20040101095 | Jing et al. | May 2004 | A1 |
20040109028 | Stern et al. | Jun 2004 | A1 |
20040109529 | Eberhard et al. | Jun 2004 | A1 |
20040127789 | Ogawa | Jul 2004 | A1 |
20040138569 | Grunwald | Jul 2004 | A1 |
20040171933 | Stoller et al. | Sep 2004 | A1 |
20040171986 | Tremaglio, Jr. et al. | Sep 2004 | A1 |
20040267157 | Miller et al. | Dec 2004 | A1 |
20050047636 | Gines et al. | Mar 2005 | A1 |
20050049521 | Miller et al. | Mar 2005 | A1 |
20050063509 | Defreitas et al. | Mar 2005 | A1 |
20050078797 | Danielsson et al. | Apr 2005 | A1 |
20050084060 | Seppi et al. | Apr 2005 | A1 |
20050089205 | Kapur | Apr 2005 | A1 |
20050105679 | Wu et al. | May 2005 | A1 |
20050107689 | Sasano | May 2005 | A1 |
20050111718 | MacMahon | May 2005 | A1 |
20050113681 | DeFreitas et al. | May 2005 | A1 |
20050113715 | Schwindt et al. | May 2005 | A1 |
20050124845 | Thomadsen et al. | Jun 2005 | A1 |
20050135555 | Claus | Jun 2005 | A1 |
20050135664 | Kaufhold | Jun 2005 | A1 |
20050226375 | Eberhard | Oct 2005 | A1 |
20060009693 | Hanover et al. | Jan 2006 | A1 |
20060018526 | Avinash | Jan 2006 | A1 |
20060025680 | Jeune-Iomme | Feb 2006 | A1 |
20060030784 | Miller et al. | Feb 2006 | A1 |
20060074288 | Kelly et al. | Apr 2006 | A1 |
20060098855 | Gkanatsios et al. | May 2006 | A1 |
20060129062 | Nicoson et al. | Jun 2006 | A1 |
20060132508 | Sadikali | Jun 2006 | A1 |
20060147099 | Marshall et al. | Jul 2006 | A1 |
20060155209 | Miller et al. | Jul 2006 | A1 |
20060197753 | Hotelling | Sep 2006 | A1 |
20060210131 | Wheeler, Jr. | Sep 2006 | A1 |
20060228012 | Masuzawa | Oct 2006 | A1 |
20060238546 | Handley | Oct 2006 | A1 |
20060257009 | Wang | Nov 2006 | A1 |
20060269040 | Mertelmeier | Nov 2006 | A1 |
20060291618 | Eberhard et al. | Dec 2006 | A1 |
20070019846 | Bullitt et al. | Jan 2007 | A1 |
20070030949 | Jing et al. | Feb 2007 | A1 |
20070036265 | Jing et al. | Feb 2007 | A1 |
20070046649 | Reiner | Mar 2007 | A1 |
20070052700 | Wheeler et al. | Mar 2007 | A1 |
20070076844 | Defreitas et al. | Apr 2007 | A1 |
20070114424 | Danielsson et al. | May 2007 | A1 |
20070118400 | Morita et al. | May 2007 | A1 |
20070156451 | Gering | Jul 2007 | A1 |
20070223651 | Wagenaar et al. | Sep 2007 | A1 |
20070225600 | Weibrecht et al. | Sep 2007 | A1 |
20070236490 | Casteele | Oct 2007 | A1 |
20070242800 | Jing et al. | Oct 2007 | A1 |
20070263765 | Wu | Nov 2007 | A1 |
20070274585 | Zhang et al. | Nov 2007 | A1 |
20080019581 | Gkanatsios et al. | Jan 2008 | A1 |
20080043905 | Hassanpourgol | Feb 2008 | A1 |
20080045833 | DeFreitas et al. | Feb 2008 | A1 |
20080101537 | Sendai | May 2008 | A1 |
20080114614 | Mahesh et al. | May 2008 | A1 |
20080125643 | Huisman | May 2008 | A1 |
20080130979 | Ren | Jun 2008 | A1 |
20080139896 | Baumgart | Jun 2008 | A1 |
20080152086 | Hall | Jun 2008 | A1 |
20080165136 | Christie et al. | Jul 2008 | A1 |
20080187095 | Boone et al. | Aug 2008 | A1 |
20080198966 | Hjarn | Aug 2008 | A1 |
20080221479 | Ritchie | Sep 2008 | A1 |
20080229256 | Shibaike | Sep 2008 | A1 |
20080240533 | Piron et al. | Oct 2008 | A1 |
20080297482 | Weiss | Dec 2008 | A1 |
20090003519 | DeFreitas | Jan 2009 | A1 |
20090005668 | West et al. | Jan 2009 | A1 |
20090010384 | Jing et al. | Jan 2009 | A1 |
20090034684 | Bernard | Feb 2009 | A1 |
20090037821 | O'Neal et al. | Feb 2009 | A1 |
20090079705 | Sizelove et al. | Mar 2009 | A1 |
20090080594 | Brooks et al. | Mar 2009 | A1 |
20090080602 | Brooks et al. | Mar 2009 | A1 |
20090080604 | Shores et al. | Mar 2009 | A1 |
20090080752 | Ruth | Mar 2009 | A1 |
20090080765 | Bernard et al. | Mar 2009 | A1 |
20090087067 | Khorasani | Apr 2009 | A1 |
20090123052 | Ruth | May 2009 | A1 |
20090129644 | Daw et al. | May 2009 | A1 |
20090135997 | Defreitas et al. | May 2009 | A1 |
20090138280 | Morita et al. | May 2009 | A1 |
20090143674 | Nields | Jun 2009 | A1 |
20090167702 | Nurmi | Jul 2009 | A1 |
20090171244 | Ning | Jul 2009 | A1 |
20090238424 | Arakita | Sep 2009 | A1 |
20090259958 | Ban | Oct 2009 | A1 |
20090268865 | Ren et al. | Oct 2009 | A1 |
20090278812 | Yasutake | Nov 2009 | A1 |
20090296882 | Gkanatsios et al. | Dec 2009 | A1 |
20090304147 | Jing et al. | Dec 2009 | A1 |
20100034348 | Yu | Feb 2010 | A1 |
20100049046 | Peiffer | Feb 2010 | A1 |
20100054400 | Ren et al. | Mar 2010 | A1 |
20100079405 | Bernstein | Apr 2010 | A1 |
20100086188 | Ruth et al. | Apr 2010 | A1 |
20100088346 | Urness et al. | Apr 2010 | A1 |
20100098214 | Star-Lack et al. | Apr 2010 | A1 |
20100105879 | Katayose et al. | Apr 2010 | A1 |
20100121178 | Krishnan | May 2010 | A1 |
20100131294 | Venon | May 2010 | A1 |
20100131482 | Linthicum et al. | May 2010 | A1 |
20100135558 | Ruth et al. | Jun 2010 | A1 |
20100152570 | Navab | Jun 2010 | A1 |
20100166267 | Zhang | Jul 2010 | A1 |
20100195882 | Ren et al. | Aug 2010 | A1 |
20100208037 | Sendai | Aug 2010 | A1 |
20100231522 | Li | Sep 2010 | A1 |
20100246909 | Blum | Sep 2010 | A1 |
20100259561 | Forutanpour et al. | Oct 2010 | A1 |
20100259645 | Kaplan | Oct 2010 | A1 |
20100260316 | Stein et al. | Oct 2010 | A1 |
20100280375 | Zhang | Nov 2010 | A1 |
20100293500 | Cragun | Nov 2010 | A1 |
20110018817 | Kryze | Jan 2011 | A1 |
20110019891 | Puong | Jan 2011 | A1 |
20110054944 | Sandberg et al. | Mar 2011 | A1 |
20110069808 | Defreitas et al. | Mar 2011 | A1 |
20110069906 | Park | Mar 2011 | A1 |
20110087132 | DeFreitas et al. | Apr 2011 | A1 |
20110105879 | Masumoto | May 2011 | A1 |
20110109650 | Kreeger | May 2011 | A1 |
20110110576 | Kreeger | May 2011 | A1 |
20110150447 | Li | Jun 2011 | A1 |
20110163939 | Tam et al. | Jul 2011 | A1 |
20110178389 | Kumar et al. | Jul 2011 | A1 |
20110182402 | Partain | Jul 2011 | A1 |
20110234630 | Batman et al. | Sep 2011 | A1 |
20110237927 | Brooks et al. | Sep 2011 | A1 |
20110242092 | Kashiwagi | Oct 2011 | A1 |
20110310126 | Georgiev et al. | Dec 2011 | A1 |
20120014504 | Jang | Jan 2012 | A1 |
20120014578 | Karssemeijer | Jan 2012 | A1 |
20120069951 | Toba | Mar 2012 | A1 |
20120131488 | Karlsson et al. | May 2012 | A1 |
20120133600 | Marshall | May 2012 | A1 |
20120133601 | Marshall | May 2012 | A1 |
20120134464 | Hoernig et al. | May 2012 | A1 |
20120148151 | Hamada | Jun 2012 | A1 |
20120189092 | Jerebko | Jul 2012 | A1 |
20120194425 | Buelow | Aug 2012 | A1 |
20120238870 | Smith et al. | Sep 2012 | A1 |
20120293511 | Mertelmeier | Nov 2012 | A1 |
20130022165 | Jang | Jan 2013 | A1 |
20130044861 | Muller | Feb 2013 | A1 |
20130059758 | Haick | Mar 2013 | A1 |
20130108138 | Nakayama | May 2013 | A1 |
20130121569 | Yadav | May 2013 | A1 |
20130121618 | Yadav | May 2013 | A1 |
20130202168 | Jerebko | Aug 2013 | A1 |
20130259193 | Packard | Oct 2013 | A1 |
20140033126 | Kreeger | Jan 2014 | A1 |
20140035811 | Guehring | Feb 2014 | A1 |
20140064444 | Oh | Mar 2014 | A1 |
20140073913 | DeFreitas et al. | Mar 2014 | A1 |
20140219534 | Wiemker et al. | Aug 2014 | A1 |
20140219548 | Wels et al. | Aug 2014 | A1 |
20140327702 | Kreeger et al. | Nov 2014 | A1 |
20140328517 | Gluncic | Nov 2014 | A1 |
20150052471 | Chen et al. | Feb 2015 | A1 |
20150061582 | Smith et al. | Apr 2015 | A1 |
20150238148 | Georgescu | Aug 2015 | A1 |
20150302146 | Marshall | Oct 2015 | A1 |
20150309712 | Marshall | Oct 2015 | A1 |
20150317538 | Ren et al. | Nov 2015 | A1 |
20150331995 | Zhao | Nov 2015 | A1 |
20160000399 | Halmann et al. | Jan 2016 | A1 |
20160022364 | DeFreitas et al. | Jan 2016 | A1 |
20160051215 | Chen | Feb 2016 | A1 |
20160078645 | Abdurahman et al. | Mar 2016 | A1 |
20160140749 | Erhard | May 2016 | A1 |
20160228034 | Gluncic | Aug 2016 | A1 |
20160235380 | Smith | Aug 2016 | A1 |
20160367210 | Gkanatsios | Dec 2016 | A1 |
20170071562 | Suzuki | Mar 2017 | A1 |
20170262737 | Rabinovich | Sep 2017 | A1 |
20180047211 | Chen et al. | Feb 2018 | A1 |
20180137385 | Ren | May 2018 | A1 |
20180144244 | Masoud | May 2018 | A1 |
20180256118 | DeFreitas | Sep 2018 | A1 |
20190015173 | DeFreitas | Jan 2019 | A1 |
20190043456 | Kreeger | Feb 2019 | A1 |
20190290221 | Smith | Sep 2019 | A1 |
20200046303 | DeFreitas | Feb 2020 | A1 |
20200093562 | DeFreitas | Mar 2020 | A1 |
20200184262 | Chui | Jun 2020 | A1 |
20200205928 | DeFreitas | Jul 2020 | A1 |
20200253573 | Gkanatsios | Aug 2020 | A1 |
20200345320 | Chen | Nov 2020 | A1 |
20200390404 | DeFreitas | Dec 2020 | A1 |
20210000553 | St. Pierre | Jan 2021 | A1 |
20210100518 | Chui | Apr 2021 | A1 |
20210100626 | St. Pierre | Apr 2021 | A1 |
20210113167 | Chui | Apr 2021 | A1 |
20220005277 | Chen | Jan 2022 | A1 |
20220013089 | Kreeger | Jan 2022 | A1 |
20220192615 | Chui | Jun 2022 | A1 |
Number | Date | Country |
---|---|---|
2014339982 | May 2016 | AU |
1846622 | Oct 2006 | CN |
202161328 | Mar 2012 | CN |
102429678 | May 2012 | CN |
107440730 | Dec 2017 | CN |
102010009295 | Aug 2011 | DE |
102011087127 | May 2013 | DE |
775467 | May 1997 | EP |
982001 | Mar 2000 | EP |
1428473 | Jun 2004 | EP |
2236085 | Jun 2010 | EP |
2215600 | Aug 2010 | EP |
2301432 | Mar 2011 | EP |
2491863 | Aug 2012 | EP |
1986548 | Jan 2013 | EP |
2656789 | Oct 2013 | EP |
2823464 | Jan 2015 | EP |
2823765 | Jan 2015 | EP |
3060132 | Apr 2019 | EP |
H09-198490 | Jul 1997 | JP |
H09-238934 | Sep 1997 | JP |
10-33523 | Feb 1998 | JP |
H10-33523 | Feb 1998 | JP |
2000-200340 | Jul 2000 | JP |
2002-282248 | Oct 2002 | JP |
2003-189179 | Jul 2003 | JP |
2003-199737 | Jul 2003 | JP |
2003-531516 | Oct 2003 | JP |
2006-519634 | Aug 2006 | JP |
2006-312026 | Nov 2006 | JP |
2007-130487 | May 2007 | JP |
2007-330334 | Dec 2007 | JP |
2007-536968 | Dec 2007 | JP |
2008-068032 | Mar 2008 | JP |
2009-034503 | Feb 2009 | JP |
2009-522005 | Jun 2009 | JP |
2009-526618 | Jul 2009 | JP |
2009-207545 | Sep 2009 | JP |
2010-137004 | Jun 2010 | JP |
2011-110175 | Jun 2011 | JP |
2012-501750 | Jan 2012 | JP |
2012011255 | Jan 2012 | JP |
2012-061196 | Mar 2012 | JP |
2013-244211 | Dec 2013 | JP |
2014-507250 | Mar 2014 | JP |
2014-534042 | Dec 2014 | JP |
2015-506794 | Mar 2015 | JP |
2015-144632 | Aug 2015 | JP |
2016-198197 | Dec 2015 | JP |
10-2015-0010515 | Jan 2015 | KR |
10-2017-0062839 | Jun 2017 | KR |
9005485 | May 1990 | WO |
9317620 | Sep 1993 | WO |
9406352 | Mar 1994 | WO |
199700649 | Jan 1997 | WO |
199816903 | Apr 1998 | WO |
0051484 | Sep 2000 | WO |
2003020114 | Mar 2003 | WO |
2005051197 | Jun 2005 | WO |
2005110230 | Nov 2005 | WO |
2005110230 | Nov 2005 | WO |
2005112767 | Dec 2005 | WO |
2005112767 | Dec 2005 | WO |
2006055830 | May 2006 | WO |
2006058160 | Jun 2006 | WO |
2007095330 | Aug 2007 | WO |
08014670 | Feb 2008 | WO |
2008047270 | Apr 2008 | WO |
2008054436 | May 2008 | WO |
2009026587 | Feb 2009 | WO |
2010028208 | Mar 2010 | WO |
2010059920 | May 2010 | WO |
2011008239 | Jan 2011 | WO |
2011043838 | Apr 2011 | WO |
2011065950 | Jun 2011 | WO |
2011073864 | Jun 2011 | WO |
2011091300 | Jul 2011 | WO |
2012001572 | Jan 2012 | WO |
2012068373 | May 2012 | WO |
2012063653 | May 2012 | WO |
2012112627 | Aug 2012 | WO |
2012122399 | Sep 2012 | WO |
2013001439 | Jan 2013 | WO |
2013035026 | Mar 2013 | WO |
2013078476 | May 2013 | WO |
WO-2013123091 | Aug 2013 | WO |
2014149554 | Sep 2014 | WO |
WO2014207080 | Dec 2014 | WO |
WO-2014207080 | Dec 2014 | WO |
2015061582 | Apr 2015 | WO |
2015066650 | May 2015 | WO |
2015130916 | Sep 2015 | WO |
2016103094 | Jun 2016 | WO |
2016184746 | Nov 2016 | WO |
2018183548 | Oct 2018 | WO |
2018183550 | Oct 2018 | WO |
WO2018183549 | Oct 2018 | WO |
2018236565 | Dec 2018 | WO |
Entry |
---|
M. Ertas, A. Akan, I. Yildirim, A. Dinler and M. Kamasak, “2D versus 3D total variation minimization in digital breast tomosynthesis,” 2015 IEEE International Conference on Imaging Systems and Techniques (IST), Macau, 2015, pp. 1-4, doi: 10.1109/IST.2015.7294553. (Year: 2015). |
B. E. Caroline and N. Vaijayanthi, “Computer aided detection of masses in digital breast tomosynthesis: A review,” 2012 International Conference on Emerging Trends in Science, Engineering and Technology (INCOSET), Tiruchirappalli, 2012, pp. 186-191, doi: 10.1109/INCOSET.2012.6513903 (Year: 2012). |
International Search Report and Written Opinion dated Jun. 8, 2018 for PCT application No. PCT/US2018/024912, applicant Hologic, Inc., 10 pages. |
Non-Final Office Action for U.S. Appl. No. 16/497,767 dated Feb. 19, 2021. |
U.S. Appl. No. 16/497,767, Office Action dated Jul. 16, 2021, 26 pages. |
PCT International Preliminary Report on Patentability in International Application PCT/US2018/024912, dated Oct. 10, 2019, 7 pages. |
“Filtered Back Projection”, (Nygren), published May 8, 2007, URL: http://web.archive.org/web/19991010131715/http://www.owlnet.rice.edu/˜elec539/Projects97/cult/node2.html, 2 pgs. |
Berg, WA et al., “Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer”, JAMA 299:2151-2163, 2008. |
Carton, AK, et al., “Dual-energy contrast-enhanced digital breast tomosynthesis—a feasibility study”, BR J Radiol. Apr. 2010;83 (988):344-50. |
Chen, SC, et al., “Initial clinical experience with contrast-enhanced digital breast tomosynthesis”, Acad Radio. Feb. 2007 14(2):229-38. |
Diekmann, F., et al., “Digital mammography using iodine-based contrast media: initial clinical experience with dynamic contrast medium enhancement”, Invest Radiol 2005; 40:397-404. |
Dromain C., et al., “Contrast enhanced spectral mammography: a multi-reader study”, RSNA 2010, 96th Scientific Assembly and Scientific Meeting. |
Dromain, C., et al., “Contrast-enhanced digital mammography”, Eur J Radiol. 2009; 69:34-42. |
Freiherr, G., “Breast tomosynthesis trials show promise”, Diagnostic Imaging—San Francisco 2005, V27; N4:42-48. |
Giger et al. “Development of a smart workstation for use in mammography”, in Proceedings of SPIE, vol. 1445 (1991), p. 101103; 4 pages. |
Giger et al., “An Intelligent Workstation for Computer-aided Diagnosis”, in RadioGraphics, May 1993, 13:3 pp. 647-656; 10 pages. |
Hologic, “Lorad StereoLoc II” Operator's Manual 9-500-0261, Rev. 005, 2004, 78 pgs. |
Hologic, Inc., 510(k) Summary, prepared Nov. 28, 2010, for Affirm Breast Biopsy Guidance System Special 510(k) Premarket Notification, 5 pages. |
Hologic, Inc., 510(k) Summary, prepared Aug. 14, 2012, for Affirm Breast Biopsy Guidance System Special 510(k) Premarket Notification, 5 pages. |
ICRP Publication 60: 1990 Recommendations of the International Commission on Radiological Protection, 12 pages. |
Jochelson, M., et al., “Bilateral Dual Energy contrast-enhanced digital mammography: Initial Experience”, RSNA 2010, 96th Scientific Assembly and Scientific Meeting, 1 page. |
Jong, RA, et al., Contrast-enhanced digital mammography: initial clinical experience. Radiology 2003; 228:842-850. |
Kopans, et al. Will tomosynthesis replace conventional mammography? Plenary Session SFN08: RSNA 2005. |
Lehman, CD, et al. MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med 2007; 356:1295-1303. |
Lewin,JM, et al., Dual-energy contrast-enhanced digital subtraction mammography: feasibility. Radiology 2003; 229:261-268. |
Lindfors, KK, et al., Dedicated breast CT: initial clinical experience. Radiology 2008; 246(3): 725-733. |
Niklason, L., et al., Digital tomosynthesis in breast imaging. Radiology. Nov. 1997; 205(2):399-406. |
Poplack, SP, et al., Digital breast tomosynthesis: initial experience in 98 women with abnormal digital screening mammography. AJR Am J Roentgenology Sep. 2007 189(3):616-23. |
Prionas, ND, et al., Contrast-enhanced dedicated breast CT: initial clinical experience. Radiology. Sep. 2010 256(3):714-723. |
Rafferty, E et al., “Assessing Radiologist Performance Using Combined Full-Field Digital Mammography and Breast Tomosynthesis Versus Full-Field Digital Mammography Alone: Results” . . . presented at 2007 Radiological Society of North America meeting, Chicago IL. |
Shrading, Simone et al., “Digital Breast Tomosynthesis-guided Vacuum-assisted Breast Biopsy: Initial Experiences and Comparison with Prone Stereotactic Vacuum-assisted Biopsy”, the Department of Diagnostic and Interventional Radiology, Univ. of Aachen, Germany, published Nov. 12, 2014, 10 pgs. |
Smith, A., “Full field breast tomosynthesis”, Radiol Manage. Sep.-Oct. 2005; 27(5):25-31. |
Weidner N, et al., “Tumor angiogenesis and metastasis: correlation in invasive breast carcinoma”, New England Journal of Medicine 1991; 324:1-8. |
Weidner, N, “The importance of tumor angiogenesis: the evidence continues to grow”, AM J Clin Pathol. Nov. 2004 122(5):696-703. |
“Supersonic to feature Aixplorer Ultimate at ECR”, AuntiMinnie.com, 3 pages (Feb. 2018). |
Bushberg, Jerrold et al., “The Essential Physics of Medical Imaging”, 3rd ed., In: “The Essential Physics of Medical Imaging, Third Edition”, Dec. 28, 2011, Lippincott & Wilkins, Philadelphia, PA, USA, XP05579051, pp. 270-272. |
Dromain, Clarisse et al., “Dual-energy contrast-enhanced digital mammography: initial clinical results”, European Radiology, Sep. 14, 2010, vol. 21, pp. 565-574. |
Reynolds, April, “Stereotactic Breast Biopsy: A Review”, Radiologic Technology, vol. 80, No. 5, Jun. 1, 2009, pp. 447M-464M, XP055790574. |
Fischer Imaging Corp, Mammotest Plus manual on minimally invasive breast biopsy system, 2002, 8 pages. (Reference labeled D13 in 01 Opposition). |
Fischer Imaging Corporation, Installation Manual, MammoTest Family of Breast Biopsy Systems, 86683G, 86684G, P-55957-IM, Issue 1, Revision 3, Jul. 2005, 98 pages. (Reference labeled D12 in 01 Opposition). |
Fischer Imaging Corporation, Operator Manual, MammoTest Family of Breast Biopsy Systems, 86683G, 86684G, P-55956-OM, Issue 1, Revision 6, Sep. 2005, 258 pages. (Reference labeled D11 in 01 Opposition). |
Koechli, Ossi R., “Available Sterotactic Systems for Breast Biopsy”, Renzo Brun del Re (Ed.), Minimally Invasive Breast Biopsies, Recent Results in Cancer Research 173:105-113; Springer-Verlag, 2009. (Reference labeled D10 in 01 Opposition). |
E. Shaw de Paredes et al., “Interventional Breast Procedure”, published Sep./Oct. 1998 in Curr Probl Diagn Radiol, pp. 138-184. (D15 in oppo). |
Burbank, Fred, “Stereotactic Breast Biopsy: Its History, Its Present, and Its Future”, published in 1996 at the Southeastern Surgical Congress, 24 pages. |
Georgian-Smith, Dianne, et al., “Stereotactic Biopsy of the Breast Using an Upright Unit, a Vacuum-Suction Needle, and a Lateral Arm-Support System”, 2001, at the American Roentgen Ray Society meeting, 8 pages. (Reference labeled D10 in 0020 Opposition). |
Samani, A. et al., “Biomechanical 3-D Finite Element Modeling of the Human Breast Using MRI Data”, 2001, IEEE Transactions on Medical Imaging, vol. 20, No. 4, pp. 271-279. |
Yin, H.M., et al., “Image Parser: a tool for finite element generation from three-dimensional medical images”, BioMedical Engineering Online. 3:31, pp. 1-9, Oct. 1, 2004. |
Sakic et al., “Mammogram synthesis using a 3D simulation. I. breast tissue model and image acquisition simulation” Medical Physics. 29, pp. 2131-2139 (2002). |
Wodajo, Felasfa, MD, “Now Playing: Radiology Images from Your Hospital PACS on your iPad,” Mar. 17, 2010; web site: http://www.imedicalapps.com/2010/03/now-playing-radiology-images-from-your-hospital-pacs-on-your-ipad/, accessed on Nov. 3, 2011 (3 pages). |
Pathmanathan et al., “Predicting tumour location by simulating large deformations of the breast using a 3D finite element model and nonlinear elasticity”, Medical Image Computing and Computer-Assisted Intervention, pp. 217-224, vol. 3217 (2004). |
Al Sallab et al., “Self Learning Machines Using Deep Networks”, Soft Computing and Pattern Recognition (SoCPaR), 2011 Int'l. Conference of IEEE, Oct. 14, 2011, pp. 21-26. |
Ghiassi, M. et al., “A Dynamic Architecture for Artificial Networks”, Neurocomputing, vol. 63, Aug. 20, 2004, pp. 397-413. |
Chan, Heang-Ping et al., “ROC Study of the effect of stereoscopic imaging on assessment of breast lesions,” Medical Physics, vol. 32, No. 4, Apr. 2005, 1001-1009. |
Lilja, Mikko, “Fast and accurate voxel projection technique in free-form cone-beam geometry with application to algebraic reconstruction,” Applies Sciences on Biomedical and Communication Technologies, 2008, Isabel '08, first international symposium on, IEEE, Piscataway, NJ, Oct. 25, 2008. |
Pediconi, “Color-coded automated signal intensity-curve for detection and characterization of breast lesions: Preliminary evaluation of new software for MR-based breast imaging,” International Congress Series 1281 (2005) 1081-1086. |
eFilm Mobile HD by Merge Healthcare, web site: http://itunes.apple.com/bw/app/efilm-mobile-hd/id405261243?mt=8, accessed on Nov. 3, 2011 (2 pages). |
eFilm Solutions, eFilm Workstation (tm) 3.4, website: http://estore.merge.com/na/estore/content.aspx?productID=405, accessed on Nov. 3, 2011 (2 pages). |
Van Schie, Guido, et al., “Mass detection in reconstructed digital breast tomosynthesis volumes with a computer-aided detection system trained on 2D mammograms”, Med. Phys. 40(4), Apr. 2013, 41902-1-41902-11. |
Van Schie, Guido, et al., “Generating Synthetic Mammograms from Reconstructed Tomosynthesis Volumes”, IEEE Transactions on Medical Imaging, vol. 32, No. 12, Dec. 2013, 2322-2331. |
Diekmann, Felix et al., “Thick Slices from Tomosynthesis Data Sets: Phantom Study for the Evaluation of Different Algorithms”, Journal of Digital Imaging, Springer, vol. 22, No. 5, Oct. 23, 2007, pp. 519-526. |
Conner, Peter, “Breast Response to Menopausal Hormone Therapy—Aspects on Proliferation, apoptosis and Mammographic Density”, 2007 Annals of Medicine, 39;1, 28-41. |
Glick, Stephen J., “Breast CT”, Annual Rev. Biomed. Eng., 2007, 9;501-26. |
Metheany, Kathrine G. et al., “Characterizing anatomical variability in breast CT images”, Oct. 2008, Med. Phys. 35 (10); 4685-4694. |
Dromain, Clarisse, et al., “Evaluation of tumor angiogenesis of breast carcinoma using contrast-enhanced digital mammography”, AJR: 187, Nov. 2006, 16 pages. |
Zhao, Bo, et al., “Imaging performance of an amorphous selenium digital mammography detector in a breast tomosynthesis system”, May 2008, Med. Phys 35(5); 1978-1987. |
Mahesh, Mahadevappa, “AAPM/RSNA Physics Tutorial for Residents—Digital Mammography: An Overview”, Nov.-Dec. 2004, vol. 24, No. 6, 1747-1760. |
Zhang, Yiheng et al., “A comparative study of limited-angle cone-beam reconstruction methods for breast tomosythesis”, Med Phys., Oct. 2006, 33(10): 3781-3795. |
Sechopoulos, et al., “Glandular radiation dose in tomosynthesis of the breast using tungsten targets”, Journal of Applied Clinical Medical Physics, vol. 8, No. 4, Fall 2008, 161-171. |
Wen, Junhai et al., “A study on truncated cone-beam sampling strategies for 3D mammography”, 2004, IEEE, 3200-3204. |
Ijaz, Umer Zeeshan, et al., “Mammography phantom studies using 3D electrical impedance tomography with numerical forward solver”, Frontiers in the Convergence of Bioscience and Information Technologies 2007, 379-383. |
Kao, Tzu-Jen et al., “Regional admittivity spectra with tomosynthesis images for breast cancer detection”, Proc. Of the 29th Annual Int'l. Conf. of the IEEE EMBS, Aug. 23-26, 2007, 4142-4145. |
Varjonen, Mari, “Three-Dimensional Digital Breast Tomosynthesis in the Early Diagnosis and Detection of Breast Cancer”, IWDM 2006, LNCS 4046, 152-159. |
Taghibakhsh, f. et al., “High dynamic range 2-TFT amplified pixel sensor architecture for digital mammography tomosynthesis”, IET Circuits Devices Syst., 2007, 1(10, pp. 87-92. |
Chan, Heang-Ping et al., “Computer-aided detection system for breast masses on digital tomosynthesis mammograms: Preliminary Experience”, Radiology, Dec. 2005, 1075-1080. |
Number | Date | Country | |
---|---|---|---|
20210118199 A1 | Apr 2021 | US |
Number | Date | Country | |
---|---|---|---|
62479008 | Mar 2017 | US |